Hebei Kangdali Pharmaceutical Co., Ltd.
AI Review Writer
The AI will rewrite your review points into a professional review.
Company Profile
Products
Seller Review
Contact Us
No Ads Found
This company hasn't posted any ads yet.
No Reviews Found
This company hasn't received any reviews yet.
Contact Us
Provide details about your needs, such as the specific products and services you require, and any questions you have for suppliers. We'll forward this information, along with your contact details, to your selected suppliers. For urgent requests, contact them directly using the information on their profiles.
About Us
Established in 1994, Hebei Kangdali Pharmaceutical Co., Ltd. is a high-tech biological company, specializing in manufacturing feed additives along with feed and health care medicine for animals. We cooperate with academy of sciences closely. The key products are choline choline, compound enzyme, compound vitamins, allicin, biology bacterium and all kinds of animal medicines. The annual output of choline chloride is over 20,000 metric tons, allicin material is over 10,000 metric tons and the compound enzyme over 20,000 metric tons. With the advanced equipment and modern control system, all our products are under the supervision of ISO9001 standards. Our products have been sold very well at home and abroad. We have set up good business relationships with more than 20 countries, such as Japan, Korea, America, Vietnam, Pakistan, Indonesia, Bahama, Mexico, Brazil, Malaysia and Poland.Our mission is that paying more attention to the heath of people and animals, developing more nuisance free and green products, and setting a good example for pharmaceutical enterprises. The motto of our company is top-class enterprise in the field of feed additive and pharmaceutical products under the famous brand "Cang Star". Based on high-tech acme, we strive to win honor by credit and to reach prosperous by hard-work.Please feel free to contact us for more information. We look forward to receiving your correspondences in the near future.